Authors: Julian Conradson Published July 2, 2022 A peer-reviewed study from researchers in France has concluded that both the experimental Pfizer and Moderna vaccines significantly increase the risk of myocarditis compared to the […]
CDC Says Moderna’s Covid-19 Vaccine Poses Greater Heart Inflammation Risk Than Pfizer
Authors: im Hoft Published June 14, 2022 Gateway Pundit Moderna’s COVID-19 vaccine may have a higher risk of heart inflammation than the Pfizer shot based on recent data, the U.S. […]
Scientists propose cause of symptoms, treatment for long COVID-19
Authors: Gary Van Beusekom | News Writer | CIDRAP News Posted June 10, 2022 Two studies to be presented at upcoming professional society meetings suggest that some long COVID-19 symptoms […]
Novavax COVID shot effective but carries heart risk, FDA says
Authors: Adriel Bettelheim Jun 3, 2022 – Axios Health Novavax’s COVID vaccine was shown to be 90% effective at preventing new cases in a clinical trial but carried the possible risk of […]
New study links COVID vaccines to 25% increase in cardiac arrest for both males & females
Study based on data from emergency services. COVID infection itself not linked to significant increase in cardiovascular complications. Authors: Y Rabinovit 31.05.22 16:20 Israeli National News From Study in Nature A […]
Vaccinated Up to 15X MORE LIKELY Than Unvaxxed to Develop Heart Inflammation Requiring Hospitalization: Peer Reviewed Study
Authors: Julian Conradson Published April 25, 2022 at 4:14pm A new study out of Europe has revealed that cases of heart inflammation that required hospitalization were much more common among vaccinated individuals […]
Prevalence of organ impairment in Long COVID patients 6 and 12 months after initial symptoms
Authors: Pooja Toshniwal PahariaMar 24 2022Reviewed by Danielle Ellis, B.Sc. In a recent study posted to the medRxiv* preprint server, researchers assessed the prevalence of organ impairment in long coronavirus disease 2019 […]
SARS-CoV-2 mRNA Vaccination-Associated Myocarditis in Children Ages 12-17: A Stratified National Database Analysis
Authors: RALPH TURCHIANO SEPTEMBER 8, 2021 • Abstract Establishing the rate of post-vaccination cardiac myocarditis in the 12-15 and 16-17-year-old population in the context of their COVID-19 hospitalization risk is critical […]
Colchicine: A Possible COVID-19 Long haul Cardiac Therapy
Last Updated: December 16, 2021 Last Updated: December 16, 2021 Colchicine is an anti-inflammatory drug that is used to treat a variety of conditions, including gout, recurrent pericarditis, and familial Mediterranean fever.1 Recently, […]
The Role of Colchicine in Pericardial Syndromes
Authors: George Lazaros 1, Massimo Imazio 2, Antonio Brucato 3, Charalambos Vlachopoulos 1, Emilia Lazarou 1, Dimitrios Vassilopoulos 4, Dimitris Tousoulis 1PMID: 29336245 DOI: 10.2174/1381612824666180116101823 Curr Pharm Des . 2018;24(6):702-709. doi: 10.2174/1381612824666180116101823. Abstract Background: Colchicine is an old drug originally employed for the treatment of inflammatory disorders […]